General American Investors’s IDENIX PHARMACEUTICALS INC IDIX Stock Holding History

General American Investors’s Portfolio IDIX Stock Details IDIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-61,369	Closed	-$1.48M	–	60
2014 Q2	$1.48M	Sell	61,369 -797,610	-93%	-$8.31M	0.12%	57
2014 Q1	$5.18M	Hold	858,979	–	–	0.43%	51
2013 Q4	$5.14M	Hold	858,979	–	–	0.42%	52
2013 Q3	$4.46M	Hold	858,979	–	–	0.39%	51
2013 Q2	$3.1M	Buy	+858,979	New	+$3.51M	0.28%	53

General American Investors's IDIX Position: Q3 2014 in Review

General American Investors sold out of IDENIX PHARMACEUTICALS INC (IDIX) in Q3 2014, closing a stake of 61,369 shares — an estimated $1.48M sold.

General American Investors first reported a position in IDIX in Q2 2013 and held it in 5 quarters. The position peaked at $5.18M in Q1 2014. 0 funds tracked by Wall St. Rank hold IDIX as of Q3 2014.

General American Investors reported no remaining IDENIX PHARMACEUTICALS INC position as of Q3 2014 after selling out during the quarter.
General American Investors sold 61,369 IDENIX PHARMACEUTICALS INC shares in Q3 2014, an estimated $1.48M.
General American Investors first reported a position in IDENIX PHARMACEUTICALS INC in Q2 2013 and held it in 5 quarters.
General American Investors's IDENIX PHARMACEUTICALS INC position peaked at $5.18M in Q1 2014.
0 funds tracked by Wall St. Rank held IDENIX PHARMACEUTICALS INC as of Q3 2014.

Based on General American Investors's 13F filing for Q3 2014, filed 20 Oct 2014.